Order results by:
| Issue | Title | |
| Vol 8, No 2 (2014) | PREGNANCY AND CHILDBIRTH IN A YOUNG WOMAN WITH CONCOMITANT MUTATION IN LEIDEN AND PROTHROMBIN GENE G20210A | Abstract similar documents |
| D. L. Kapanadze | ||
| Vol 14, No 1 (2020) | Management of pregnancy and labor in female with combination of homozygous Leiden and heterozygous prothrombin G20210A mutations | Abstract similar documents |
| M. O. Arslanbekova, J. Kh. Khizroeva | ||
| "... with multigenic thrombophilia (combination of homozygous Leiden and heterozygous prothrombin G20210A mutations ..." | ||
| Vol 15, No 6 (2021) | Antiphospholipid antibodies, genetic thrombophilia and fetal growth retardation | Abstract similar documents |
| E. A. Orudzhova | ||
| "... method; prothrombin gene polymorphisms G20210A and factor V Leiden – by polymerase chain reaction ..." | ||
| Vol 14, No 2 (2020) | Gestational complications of the prothrombin G20210A mutation related to prothrombin activity | Abstract similar documents |
| M. G. Nikolaeva, N. N. Yasafova, A. P. Momot, M. S. Zainulina, K. A. Momot, I. A. Taranenko | ||
| "... complications in women with the prothrombin G20210A mutation. Materials and methods. A prospective clinical ..." | ||
| Vol 13, No 3 (2019) | Venous thrombosis in pregnant women: genetic and epigenetic risk factors | Abstract PDF (Eng) similar documents |
| I. Elalamy | ||
| "... coagulation – proteins C and S, antithrombin III, Leiden mutation, prothrombin anomaly G 202110A. Thus ..." | ||
| Vol 15, No 2 (2021) | Cerebral circulation disorders in women using combined oral contraceptives | Abstract similar documents |
| M. D. Andreeva, M. G. Novosartyan, N. V. Samburova, I. V. Khamani | ||
| "... of most thrombogenic genetic polymorphisms such as mutated Factor V Leiden gene, prothrombin G20210А gene ..." | ||
| Vol 8, No 1 (2014) | PREGNANCY AND CHILDBIRTH IN WOMEN WITH COMBINED THROMBOPHILIA, HISTORY THROMBOSIS AND PREECLAMPSIA | Abstract similar documents |
| D. L. Kapanadzhe | ||
| Vol 11, No 4 (2017) | ROLE OF GENETIC THROMBOPHILIA IN THE DEVELOPMENT OF THROMBOEMBOLIC AND OBSTETRIC COMPLICATIONS | Abstract similar documents |
| D. L. Kapanadze, T. A. Diakonidze, V. B. Zubenko | ||
| Vol 15, No 5 (2021) | Pathogenetically justified tactics of management of pregnancy with retrochorial hematoma | Abstract similar documents |
| K. G. Sultangadzhieva, N. N. Babaeva, E. S. Egorova, J. Kh. Khizroeva, M. G. Sultangadzhiev | ||
| "... in the genes of factor (F) V Leiden and prothrombin (FII) G20210A; blood levels of lupus anticoagulant (LA ..." | ||
| Vol 8, No 1 (2014) | CEREBRAL VENOUS THROMBOSIS IN OBSTETRICS AND GYNECOLOGY | Abstract similar documents |
| A. D. Makatsariya, S. V. Akinshina, V. O. Bitsadze | ||
| "... in the pathogenesis of thrombophilic states of cerebral thrombosis, especially FV Leiden mutation and prothrombin G ..." | ||
| Vol 9, No 1 (2015) | GENETIC RISK FACTORS OF TROMBOPHILIA IN WOMEN OF REPRODUCTIVE AGE RESIDING IN KRASNODAR REGION | Abstract similar documents |
| A. S. Adamchik, D. I. Panchenko | ||
| "... patients) at low percent of incidence of factor V (Leiden) and factor II (prothrombin) gene mutation ..." | ||
| Vol 12, No 2 (2018) | Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype) | Abstract similar documents |
| M. G. Nikolaeva, A. P. Momot, M. S. Zainulina, K. A. Momot, N. N. Yasafova | ||
| "... -resistance with NR ≤ 0.49) Factor V Leiden mutation (GA genotype). Materials and methods. A single-center ..." | ||
| Vol 8, No 3 (2014) | ON THE ISSUE OF PROTEIN C SYSTEM DISORDERS IN PREGNANT WOMEN WITH VARIOUS OBSTETRIC PATHOLOGY IN PAST HISTORY | Abstract similar documents |
| I. A. Mikhaylidi | ||
| Vol 12, No 1 (2018) | MANAGEMENT OF PREGNANCY AND DELIVERY IN A WOMAN WITH HOMOZYGOUS MUTATION OF PROTHROMBIN (Thr165Met) AND RECURRENT PULMONARY EMBOLISM ON THE BACKGROUND OF HORMONAL CONTRACEPTION | Abstract similar documents |
| N. M. Khamani | ||
| "... was indicative of a hereditary element of the disease. Here, homozygous mutation of prothrombin factor II (Thr165 ..." | ||
| Vol 19, No 1 (2025) | Genetic thrombophilia and antiphospholipid antibodies in women with early and late preeclampsia: a retrospective cohort study | Abstract similar documents |
| A. S. Antonova, J. Kh. Khizroeva, V. O. Bitsadze, M. V. Tretyakova, N. A. Makatsariya, E. R. Efendieva, A. Yu. Shatilina, E. M. Lyadnova | ||
| "... often had genetic forms of thrombophilia (mutations in factor (F) V Leiden gene, prothrombin G20210A ..." | ||
| Vol 16, No 2 (2022) | Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia | Abstract similar documents |
| E. A. Orudzhova, V. O. Bitsadze, M. V. Tretyakova, D. A. Doronicheva, F. Yakubova | ||
| "... polymorphisms G20210A as well as factor V Leiden polymorphism – by chain reaction; homocysteine – by ELISA ..." | ||
| Vol 12, No 1 (2018) | THROMBOPHILIA AND ABNORMAL LOCATION OF PLACENTA | Abstract similar documents |
| V. B. Zubenko | ||
| "... in the 5,10-methylenetetrafolate reductase gene, the prothrombin mutation in the G20210A gene, mutations ..." | ||
| Vol 16, No 5 (2022) | Clinical significance of hemostasiological screening for thrombophilia in pregnant women with former thrombosis | Abstract similar documents |
| J. Kh. Khizroeva, N. N. Babaeva, N. A. Makatsariya, I. Elalamy, J-C. Gris | ||
| "... activator inhibitor-1 (PAI-1), coagulation factor II (prothrombin; F2: Thr165Met), coagulation factor I ..." | ||
| Vol 17, No 4 (2023) | Features of pregnancy course in patients with thrombophilia and abnormal placenta location | Abstract similar documents |
| V. B. Zubenko, A. I. Lovkova | ||
| "... in prothrombin gene, V Leiden mutation, polymorphismin fibrinogen and plasminogen activator inhibitor 1 (PAI-1 ..." | ||
| Vol 19, No 1 (2025) | Pathology of placenta placement and thrombophilia: an inconspicuous connection | Abstract similar documents |
| V. B. Zubenko, M. V. Tretyakova, E. S. Kudryavtseva, I. S. Kalashnikova, A. Yu. Shatilina, A. E. Einullaeva, D. V. Blinov, S. E. Ausheva | ||
| "... (MTHFR) gene, mutations in the prothrombin gene G20210A, factor V Leiden mutations, assessment of present ..." | ||
| Vol 15, No 3 (2021) | Thrombophilia identified as a risk factor for thrombogenesis in cancer patients | Abstract similar documents |
| A. V. Vorobev, A. D. Makatsariya, V. O. Bitsadze, A. G. Solopova, D. A. Ponomarev | ||
| "... of circulating APA was studied: antibodies to â2-glycoprotein I (â2-GPI), annexin V and prothrombin as well ..." | ||
| Vol 8, No 4 (2014) | ROLE OF GENE POLYMORPHISMS IN GENESIS OF GESTATIONAL COMPLICATIONS AT PREGNANT WOMEN WITH OBESITY | Abstract similar documents |
| Z. M. Dubossarskaya, Yu. M. Duka | ||
| "... , a mutation of factors of a fibrillation of F5 Leiden, F7, PAI gene-1, MTR gene is revealed: 2756 – B12 ..." | ||
| Vol 19, No 2 (2025) | Pathogenetic approach to the treatment of coagulopathic bleeding in obstetrics | Abstract similar documents |
| T. A. Sushko, M. S. Zainulina | ||
| "... , prothrombin index, activated partial thromboplastin time (APTT), Claus fibrinogen level, international ..." | ||
| Vol 18, No 2 (2024) | Clinical significance for assessing adaptive hemostasis changes during multiple pregnancy after in vitro fertilization | Abstract similar documents |
| F. Е. Yagubova, V. O. Bitsadze, N. V. Samburova, J. Kh. Khizroeva, A. D. Makatsariya | ||
| "... . Hemostasis parameters were studied as follows: activated partial thromboplastin time (APTT), prothrombin time ..." | ||
| Vol 18, No 2 (2024) | Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19 | Abstract similar documents |
| Yu. V. Mikhailova, N. V. Chepurchenko, A. P. Obriadina | ||
| "... , phosphatidylserine-prothrombin complex (PS-PT) by using domestically produced test systems based on indirect two-step ..." | ||
| Vol 14, No 1 (2020) | Pathogenetically differentiated management of pregnancy in patients with retrochorial hematoma | Abstract similar documents |
| Kh. G. Sultangadzhieva, J. Kh. Khizroeva | ||
| "... and prothrombin, and ADAMTS-13. All women were examined for genetic mutations linked to high thrombogenic risk ..." | ||
| Vol 14, No 4 (2020) | Hemostasis in pregnant, parturient and puerperal women with preeclampsia | Abstract similar documents |
| M. G. Mustafin, E. Yu. Yupatov, T. E. Kurmanbaev, R. M. Nibiullina, Yu. L. Timoshkova, A. A. Shmidt, N. V. Yakovlev | ||
| "... , prothrombin, international normalized ratio) as well as assay for early diagnostics of blood clotting ..." | ||
| Vol 17, No 1 (2023) | Opportunities for predicting adverse pregnancy outcomes in severe COVID-19 | Abstract similar documents |
| V. F. Bezhenar, I. A. Dobrovolskaya, I. M. Nesterov, A. V. Schegolev, A. N. Kucheryavenko, S. G. Meshchaninova, V. S. Pakin, A. A. Nikulin | ||
| "... , total protein; coagulation parameters – prothrombin level according to Quick and fibrinogen, activated ..." | ||
| Vol 18, No 1 (2024) | Antiphospholipid antibodies as a potential factor of tumor progression | Abstract similar documents |
| Z. D. Aslanova, J. Kh. Khizroeva, A. G. Solopova, V. O. Bitsadze, A. V. Vorobev, J.-C. Gris, I. Elalamy, N. A. Makatsariya, D. Yu. Zabolotnaya | ||
| "... -phosphatidylserine-prothrombin complex antibodies (anti-PS-PT) IgG and IgM by using enzyme-linked immunosorbent assay ..." | ||
| Vol 14, No 2 (2020) | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome | Abstract PDF (Eng) similar documents |
| A. D. Makatsariya, K. N. Grigoreva, M. A. Mingalimov, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, I. Elalamy, A. S. Shkoda, V. B. Nemirovskiy, D. V. Blinov, D. V. Mitryuk | ||
| "... level, prothrombin time, platelet count and fibrinogen content is important for determining indications ..." | ||
| Vol 9, No 3 (2015) | CLINICAL LABORATORY INDICATORS OF PREGNANT WITH ANTIPHOSPHOLIPID SYNDROME IN COMPLEX THERAPY WITH USING INTRAVENOUS IMMUNOGLOBULIN | Abstract similar documents |
| V. I. Linnikov | ||
| "... , аннексину V, протромбину. Диагностика тромбофилического состояния крови включала определение агрегации ..." | ||
| Vol 15, No 4 (2021) | Mathematical modeling of pregnancy loss with normal embryo karyotype in the first trimester | Abstract similar documents |
| N. N. Potapov, E. V. Kudryavtseva, V. V. Kovalev | ||
| "... and laboratory examination, analysis of genetic polymorphisms (FGBG -455A, F2 G20210A, F5 G1691A, F7 G10976A, F13 ..." | ||
| Vol 12, No 1 (2018) | POLYMORPHISM OF THE HAEMOSTASIS GENES IN WOMEN WITH THREATENED PRETERM DELIVERY | Abstract similar documents |
| A. I. Malyshkina, I. N. Fetisova, Yu. N. Zholobov, A. O. Nazarova, S. Yu. Ratnikova, N. S. Fetisov, S. B. Nazarov | ||
| "... », Russia). Single nucleotide polymorphisms (F2 G20210A, F5 G1691А, F7 G10976A, F13A1 G/T, FGB G -455A, PAI ..." | ||
| Vol 16, No 2 (2022) | Anticoagulants: dose control methods and inhibitors | Abstract PDF (Eng) similar documents |
| V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, V. I. Tsibizova, N. R. Gashimova, I. A. Nakaidze, I. Elalamy, J.-C. Gris, A. D. Makatsariya | ||
| "... . Inhibitors of other anticoagulants are universal presented as inactivated or activated prothrombin complex ..." | ||
| Vol 14, No 2 (2020) | Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers | Abstract PDF (Eng) similar documents |
| J. H. Khizroeva, A. D. Makatsariya, V. O. Bitsadze, M. V. Tretyakova, E. V. Slukhanchuk, I. Elalamy, J.-C. Gris, L. S. Radetskaya, N. A. Makatsariya, Ya. Yu. Sulina, V. I. Tsibizova, A. S. Shkoda, D. V. Blinov | ||
| "... thrombocytopenia. Hyperfibrinogenemia, increased D-dimer level, prolonged prothrombin time, thrombocytopenia ..." | ||
| Vol 15, No 2 (2021) | Risks of cerebrovascular disorders associated with combined hormonal contraceptives | Abstract similar documents |
| M. G. Novosartyan | ||
| "... .5 %) case of Leiden factor V mutation compared to patients with venous blood flow disorders (p < 0 ..." | ||
| Vol 16, No 3 (2022) | Hemostasis features in pregnant women with hypertensive disorders living in the highlands of Tadzhikistan Republic | Abstract similar documents |
| N. A. Tadzhiboeva, A. G. Yashchuk, I. B. Fatkullina, S. A. Galeeva, A. Yu. Lazareva, N. A. Stetsenko, D. G. Sitdikova | ||
| "... parameters were studied: blood clotting time, prothrombin index, content of fibrinogen and soluble fibrin ..." | ||
| Vol 15, No 2 (2021) | Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation | Abstract similar documents |
| O. L. Mysik, M. S. Zainulina | ||
| "... hemostasis parameters: via markedly increased platelet count, decreased fibrinogen level, prothrombin index ..." | ||
| 1 - 39 of 39 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
